Squarepoint Ops LLC Avenue Therapeutics, Inc. Transaction History

Squarepoint Ops LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$2.41 - $7.11 $28,119 - $82,959	-11,668 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$4.7 - $7.17 $54,839 - $83,659	11,668 New	11,668 $71,000
Q3 2020 Nov 16, 2020	SELL	$9.37 - $12.06 $205,474 - $264,463	-21,929 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$8.29 - $11.47 $20,882 - $28,892	2,519 Added 12.98%	21,929 $236,000
Q1 2020 May 15, 2020	BUY	$6.44 - $11.32 $125,000 - $219,721	19,410 New	19,410 $174,000
Q4 2019 Feb 14, 2020	SELL	$5.26 - $9.6 $66,938 - $122,169	-12,726 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$5.58 - $6.3 $71,011 - $80,173	12,726 New	12,726 $76,000

Ticker ATXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,127,720
Market Cap $9.25M
Description
Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was in...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.